nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00144	0.00144	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTH1R—osteoporosis	0.00144	0.00144	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CALCR—osteoporosis	0.00144	0.00144	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PTH—osteoporosis	0.00141	0.00141	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—OXCT1—osteoporosis	0.0014	0.0014	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CA2—osteoporosis	0.0014	0.0014	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SOST—osteoporosis	0.00139	0.00139	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CNR2—osteoporosis	0.00137	0.00137	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PTH—osteoporosis	0.00137	0.00137	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MGLL—osteoporosis	0.00137	0.00137	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ATIC—osteoporosis	0.00134	0.00134	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PNP—osteoporosis	0.00134	0.00134	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00134	0.00134	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CNR2—osteoporosis	0.00134	0.00134	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SOST—osteoporosis	0.00129	0.00129	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.00129	0.00129	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PTH—osteoporosis	0.00128	0.00128	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.00128	0.00128	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—POMC—osteoporosis	0.00128	0.00128	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CALCR—osteoporosis	0.00126	0.00126	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTH1R—osteoporosis	0.00126	0.00126	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—WNT1—osteoporosis	0.00126	0.00126	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—PTHLH—osteoporosis	0.00125	0.00125	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00125	0.00125	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CNR2—osteoporosis	0.00125	0.00125	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PTH—osteoporosis	0.00123	0.00123	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MGLL—osteoporosis	0.00123	0.00123	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CNR2—osteoporosis	0.0012	0.0012	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LRP5—osteoporosis	0.0012	0.0012	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—WNT1—osteoporosis	0.00117	0.00117	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CALCR—osteoporosis	0.00117	0.00117	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTH1R—osteoporosis	0.00117	0.00117	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PTHLH—osteoporosis	0.00117	0.00117	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—IDH2—osteoporosis	0.00116	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PTH—osteoporosis	0.00115	0.00115	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MGLL—osteoporosis	0.00114	0.00114	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LRP6—osteoporosis	0.00114	0.00114	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CA2—osteoporosis	0.00114	0.00114	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—OXCT1—osteoporosis	0.00114	0.00114	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PTHLH—osteoporosis	0.00114	0.00114	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PTH—osteoporosis	0.00112	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LRP5—osteoporosis	0.00112	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	0.00112	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MGLL—osteoporosis	0.00111	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CALCA—osteoporosis	0.0011	0.0011	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP27A1—osteoporosis	0.00109	0.00109	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00109	0.00109	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CNR2—osteoporosis	0.00109	0.00109	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LRP6—osteoporosis	0.00107	0.00107	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ACP5—osteoporosis	0.00106	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PTHLH—osteoporosis	0.00106	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PTH—osteoporosis	0.00104	0.00104	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CALCA—osteoporosis	0.00103	0.00103	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—WNT1—osteoporosis	0.00103	0.00103	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PTHLH—osteoporosis	0.00102	0.00102	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.00102	0.00102	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—POMC—osteoporosis	0.00102	0.00102	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00102	0.00102	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	0.00101	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CALCA—osteoporosis	0.001	0.001	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MGLL—osteoporosis	0.001	0.001	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—TPI1—osteoporosis	0.000989	0.000989	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LRP5—osteoporosis	0.000976	0.000976	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TLN1—osteoporosis	0.000966	0.000966	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	0.000953	0.000953	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000953	0.000953	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—POMC—osteoporosis	0.000953	0.000953	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	0.000949	0.000949	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—IDH2—osteoporosis	0.000945	0.000945	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CALCA—osteoporosis	0.000934	0.000934	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LRP6—osteoporosis	0.000934	0.000934	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—P4HB—osteoporosis	0.00093	0.00093	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MGLL—osteoporosis	0.00093	0.00093	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	0.000928	0.000928	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GAPDH—osteoporosis	0.000913	0.000913	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LRP5—osteoporosis	0.000907	0.000907	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TLN1—osteoporosis	0.000902	0.000902	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	0.0009	0.0009	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—RAP1A—osteoporosis	0.000889	0.000889	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP27A1—osteoporosis	0.000889	0.000889	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—IGF1—osteoporosis	0.000877	0.000877	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LRP6—osteoporosis	0.000868	0.000868	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ACP5—osteoporosis	0.000865	0.000865	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	0.000862	0.000862	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	0.000836	0.000836	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—POMC—osteoporosis	0.000833	0.000833	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—P4HB—osteoporosis	0.000833	0.000833	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—IGF1—osteoporosis	0.000819	0.000819	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	0.000817	0.000817	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PTH—osteoporosis	0.00081	0.00081	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—TPI1—osteoporosis	0.000804	0.000804	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RAP1A—osteoporosis	0.000796	0.000796	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CNR2—osteoporosis	0.000789	0.000789	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TLN1—osteoporosis	0.000789	0.000789	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—ADCY5—osteoporosis	0.000784	0.000784	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—P4HB—osteoporosis	0.000778	0.000778	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NFATC1—osteoporosis	0.000777	0.000777	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000774	0.000774	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—POMC—osteoporosis	0.000774	0.000774	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DKK1—osteoporosis	0.000771	0.000771	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	0.000759	0.000759	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTH—osteoporosis	0.000757	0.000757	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—P4HB—osteoporosis	0.000756	0.000756	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RAP1A—osteoporosis	0.000744	0.000744	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—WNT1—osteoporosis	0.000742	0.000742	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GAPDH—osteoporosis	0.000742	0.000742	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CNR2—osteoporosis	0.000737	0.000737	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TLN1—osteoporosis	0.000733	0.000733	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—ADCY5—osteoporosis	0.000732	0.000732	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NFATC1—osteoporosis	0.000725	0.000725	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—RAP1A—osteoporosis	0.000722	0.000722	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FGA—osteoporosis	0.000722	0.000722	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DKK1—osteoporosis	0.00072	0.00072	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ENO1—osteoporosis	0.000719	0.000719	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	0.000712	0.000712	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PSMA2—osteoporosis	0.000708	0.000708	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PSMA5—osteoporosis	0.000708	0.000708	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—WNT1—osteoporosis	0.000693	0.000693	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—P4HB—osteoporosis	0.00068	0.00068	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FGA—osteoporosis	0.000674	0.000674	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	0.000671	0.000671	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—BMP2—osteoporosis	0.000671	0.000671	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—IGF1—osteoporosis	0.000666	0.000666	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	0.000665	0.000665	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTH—osteoporosis	0.000662	0.000662	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FGB—osteoporosis	0.000657	0.000657	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	0.00065	0.00065	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CNR2—osteoporosis	0.000645	0.000645	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000642	0.000642	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	0.00064	0.00064	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	0.000634	0.000634	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	0.000634	0.000634	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	0.000634	0.000634	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—P4HB—osteoporosis	0.000632	0.000632	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DKK1—osteoporosis	0.000629	0.000629	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	0.000627	0.000627	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—BMP2—osteoporosis	0.000627	0.000627	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTH—osteoporosis	0.000615	0.000615	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FGB—osteoporosis	0.000614	0.000614	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—WNT1—osteoporosis	0.000606	0.000606	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	0.000604	0.000604	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CNR2—osteoporosis	0.000599	0.000599	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	0.000595	0.000595	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	0.000592	0.000592	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	0.000592	0.000592	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CALCA—osteoporosis	0.000591	0.000591	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FGA—osteoporosis	0.00059	0.00059	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	0.000589	0.000589	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DKK1—osteoporosis	0.000585	0.000585	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ENO1—osteoporosis	0.000584	0.000584	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	0.000581	0.000581	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	0.000576	0.000576	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PSMA5—osteoporosis	0.000575	0.000575	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PSMA2—osteoporosis	0.000575	0.000575	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP19A1—osteoporosis	0.000575	0.000575	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—WNT1—osteoporosis	0.000563	0.000563	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CALCA—osteoporosis	0.000552	0.000552	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	0.000548	0.000548	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—BMP2—osteoporosis	0.000548	0.000548	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGA—osteoporosis	0.000548	0.000548	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	0.00054	0.00054	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	0.000538	0.000538	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—KL—osteoporosis	0.000537	0.000537	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FGB—osteoporosis	0.000536	0.000536	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TGFB1—osteoporosis	0.000526	0.000526	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—POMC—osteoporosis	0.000523	0.000523	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	0.000518	0.000518	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	0.000518	0.000518	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	0.000511	0.000511	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	0.000509	0.000509	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—BMP2—osteoporosis	0.000509	0.000509	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KL—osteoporosis	0.000501	0.000501	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGB—osteoporosis	0.000498	0.000498	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TGFB1—osteoporosis	0.000491	0.000491	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—POMC—osteoporosis	0.000489	0.000489	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CALCA—osteoporosis	0.000483	0.000483	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	0.000481	0.000481	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	0.000481	0.000481	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	0.000477	0.000477	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	0.000471	0.000471	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ADCY5—osteoporosis	0.00047	0.00047	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GPX1—osteoporosis	0.000468	0.000468	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP19A1—osteoporosis	0.000467	0.000467	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CALCA—osteoporosis	0.000448	0.000448	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KL—osteoporosis	0.000438	0.000438	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	0.000437	0.000437	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MTHFR—osteoporosis	0.000432	0.000432	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—POMC—osteoporosis	0.000427	0.000427	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	0.00042	0.00042	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	0.000417	0.000417	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KL—osteoporosis	0.000407	0.000407	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SPP1—osteoporosis	0.000407	0.000407	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TGFB1—osteoporosis	0.000399	0.000399	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—POMC—osteoporosis	0.000397	0.000397	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	0.000393	0.000393	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	0.000387	0.000387	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ADCY5—osteoporosis	0.000381	0.000381	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GPX1—osteoporosis	0.00038	0.00038	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SPP1—osteoporosis	0.00038	0.00038	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IRS2—osteoporosis	0.000368	0.000368	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LEP—osteoporosis	0.00036	0.00036	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MTHFR—osteoporosis	0.000351	0.000351	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—POMC—osteoporosis	0.000345	0.000345	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ESR1—osteoporosis	0.000344	0.000344	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IRS2—osteoporosis	0.000344	0.000344	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	0.000343	0.000343	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LEP—osteoporosis	0.000336	0.000336	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SPP1—osteoporosis	0.000332	0.000332	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IRS1—osteoporosis	0.000321	0.000321	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ESR1—osteoporosis	0.000321	0.000321	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	0.000319	0.000319	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—POMC—osteoporosis	0.000309	0.000309	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SPP1—osteoporosis	0.000309	0.000309	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6R—osteoporosis	0.000302	0.000302	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IRS2—osteoporosis	0.0003	0.0003	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IRS1—osteoporosis	0.0003	0.0003	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF1—osteoporosis	0.000297	0.000297	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LEP—osteoporosis	0.000294	0.000294	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—POMC—osteoporosis	0.000289	0.000289	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6R—osteoporosis	0.000282	0.000282	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ESR1—osteoporosis	0.000281	0.000281	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—POMC—osteoporosis	0.000281	0.000281	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IRS2—osteoporosis	0.000279	0.000279	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF1—osteoporosis	0.000278	0.000278	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LEP—osteoporosis	0.000273	0.000273	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IRS1—osteoporosis	0.000262	0.000262	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ESR1—osteoporosis	0.000261	0.000261	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—POMC—osteoporosis	0.000252	0.000252	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6R—osteoporosis	0.000246	0.000246	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IRS1—osteoporosis	0.000244	0.000244	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF1—osteoporosis	0.000243	0.000243	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—POMC—osteoporosis	0.000235	0.000235	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6R—osteoporosis	0.000229	0.000229	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—osteoporosis	0.000227	0.000227	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF1—osteoporosis	0.000226	0.000226	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—osteoporosis	0.000212	0.000212	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—osteoporosis	0.000186	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MYC—osteoporosis	0.000179	0.000179	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	0.000178	0.000178	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—osteoporosis	0.000173	0.000173	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MYC—osteoporosis	0.000167	0.000167	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	0.000167	0.000167	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MYC—osteoporosis	0.000146	0.000146	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	0.000146	0.000146	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MYC—osteoporosis	0.000136	0.000136	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	0.000135	0.000135	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—osteoporosis	0.000134	0.000134	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—osteoporosis	0.000126	0.000126	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—osteoporosis	0.00011	0.00011	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—osteoporosis	0.000102	0.000102	CbGpPWpGaD
